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Intact platelets were stimulated with thrombin and the amount of GTP-binding protein (G-protein) oli- 
gomers was assessed by measuring ADP ribosylation of 40-41 kDa protein by pertussis toxin in isolated 
membranes. The toxin substrate fell by 57-625 in lo-60 s, but then returned towards normal over 5 min. 
Recovery was greatly enhanced by removal of thrombin from receptors with hirudin. Phorbol myristate 
acetate increased ADP-ribosylatable protein, but oniy back to initial levels prior to PMA. In contrast pros- 
taglandin Dz plus theophylline (which increase cyclic AMP) did not increase ADP ribosyiation, but could 
completely block the fall of the toxin substrate caused by thrombin. These results indicate that activation 
of thrombin receptors promotes the dissociation of G-protein oligomers to release free cc-subunits, and this 
effect can be modulated by protein kinase C and cyclic AMP-dependent protein kinase. The possible rela- 
tionships of these findings to the regulation of stimulus-response coupling in platelets is discussed. 
Thrombin Phorbol ester Prostaglandin Dt Pertussis toxin 
1, INTRODUCTION 
The catalytic activity of adenylate cyclase is 
regulated by the relative states of dissociation of 
the guanine nucleotide-binding proteins (G- 
proteins) G, and Gi, which are under the control of 
hormones or agonists and their receptors [l]. Cer- 
tain G-proteins are now also believed to be in- 
volved in stimulus-response coupling by regulating 
the activity of the specific phosphodiesterase that 
hydrolyzes PIP2 to form diacylglycerol and the 
Ca2+-mobilizing agent IP3 [2-61. Pertussis toxin, 
which causes ADP ribosylation of the a! 
(nucleotide-binding) subunit of intact Grd;Br 
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oligomers, prevents the dissociation of Gi subunits 
from the -oligomer [7], and blocks inhibition of 
adenylate cyclase by receptors linked to Gi. The 
toxin also inhibits agonist-induced PIP;? 
breakdown and calcium mobilization in 
neutrophils f8-lo], basophilic leukemia cells [ll J, 
adipocytes [12], and mast cells [ 131. However, 
stimulation of other cell types by hormones and 
agonists, although GTP-dependent, is not in- 
hibited by pertussis toxin [6,14,15], and therefore 
may involve G-proteins which like Go are less 
susceptible to the toxin [16]. 
Thrombin causes breakdown of PIP2 in platelets 
with resultant formation of IP3 [17] and 
diacylglycerol [ 181, and mobilization of calcium 
[19]. Adenylate cyclase activity is also inhibited. 
Only the latter effect has been shown to be 
mediated by receptors linked to Gi, which can be 
inhibited by pertussis toxin in membrane fractions 
[ZO]. Intact platelets are not susceptible to pertussis 
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toxin, presumably owing to lack of surface recep- 
tors necessary for its internalization [21]. 
However, in permeabilized platelets GTP poten- 
tiates formation of diacylglycerol and the secretion 
caused by calcium and thrombin [22,23], in- 
dicating that G-proteins may play a role in 
stimulus-response coupling in platelets apart from 
regulation of adenylate cyclase. 
To investigate the state of association of G- 
protein oligomers in intact platelets we assayed the 
amount of ADP-ribosylatable protein in mem- 
branes isolated from platelets that were stimulated 
by the agonist. Pertussis toxin ADP ribosylates the 
41 kDa a-subunit of the intact Gi-cu;Br oligomer, 
and not free (Y (with or without bound nucleotide) 
[24-261. By this approach we obtained the first 
direct evidence that thrombin causes a reversible 
dissociation of G-protein oligomers in intact 
platelets. Furthermore, this effect was blocked by 
PGD2, which increases cyclic AMP. We also pre- 
sent evidence that the state of dissociation/associa- 
tion of the pertussis toxin substrate is also 
modulated by protein kinase C. 
2. MATERIALS AND METHODS 
2.1. Preparation of washed platelets and 
treatment with thrombin, PGDz, and PMA 
Human platelets from the Connecticut Red 
Cross Blood Center were washed as described [20], 
resuspended in 70 ml of 145 mM NaCl, 5 mM 
KCl, 10 mM Hepes (PH 7.4), 0.2 mM EGTA, 
5.5 mM dextrose, and then pelleted at 750 x g 
(10 min). The platelets were resuspended to 5 x lo9 
cells/ml in 10 mM Hepes (pH 7.4)-saline (as 
above) containing 2 mM EGTA and 1 mM MgClz, 
and 1.0-2.0 ml aliquots were incubated at 37°C 
for 10 min. Thrombin, and/or other agents, were 
added to the platelets and the incubations con- 
tinued for the prescribed times, until terminated by 
the addition of 5.0 ml ice-cold medium containing 
1 U/ml of hirudin and immediately placed in an 
ice bath. The platelet membrane fraction was 
isolated at 0-4°C as described below. 
2.2. Preparation of platelet membranes and ADP 
ribosylation 
Platelets were pelleted at 750 x g (Sorvall RC 5B 
centrifuge) and resuspended in 30 ml of hypotonic 
medium: 1 mM KHCO3 (pH 8.3), 1 mM EGTA, 
342 
10,uM pepstatin, 1OpM leupeptin and 0.5 mM 
diisopropylfluorophosphate, and stored on ice for 
30-45 min. The swollen platelets were centrifuged 
at 7700 x g (10 min), resuspended in 6 ml 
hypotonic medium, and homogenized by 20 
strokes in a stainless steel Dounce homogenizer 
with a tight fitting pestle. Unbroken cells were 
removed by centrifugation at 3000 x g (10 min) 
and the supernatants were diluted to 40 ml in 
ADP-ribosylation medium: 0.1 M sucrose, 
0.67 mM EDTA, 1 mM ATP, 2.5 mM MgCL, 
10 mM thymidine, 0.5 mM DFP, 12 /IM 
[32P]NAD (2 Ci/mol), 1.3 mM DTT, 13.3 mM 
potassium phosphate and 5 mM Tris-HCI, final 
pH 7.2. Membranes were obtained by centrifuga- 
tion at 39000 x g for 30 min, then washed and 
resuspended to l-3 mg protein/ml in ADP- 
ribosylation medium. The reaction was started by 
adding 17 fig/ml of pertussis toxin preactivated 
with 10 mM DTT at 30°C for 10 min, and ter- 
minated after 20 min by adding (to 50 pl of mem- 
brane suspension) 25 pl of stopping-solution: 9% 
SDS, 15% glycerol, 0.05% bromophenol blue, 6% 
,%mercaptoethanol and 86 mM Tris-HCl, pH 6.7. 
The samples were heated in a boiling water bath 
and the proteins were separated [27] on 10.5% 
polyacrylamide gels with 0.1% SDS. The gels were 
dried and exposed to Kodak XAR-5 film over- 
night. The amount of radioactive 40-41 kDa pro- 
tein was determined by densitometry of the X-ray 
film. 
3. RESULTS AND DISCUSSION 
Platelets from 10 donors were exposed to throm- 
bin at concentrations of 0.5, 1.0 and 2.0 units/ml 
(0.1-0.4 U/lo9 platelets) for 30 s at 37’C and the 
amount of ADP-ribosylatable protein was 
measured in the membrane fraction after gel elec- 
trophoresis (fig. 1A). Stimulation by thrombin 
caused the amount of [32P]ADP-ribosylated G- 
protein to fall to only 38% to 43% of the control 
level (table 1). Since the a-subunit of Gi oligomers, 
but not free u-subunit, is a substrate for ADP 
ribosylation these results probably indicate that 
dissociation of G-protein oligomers occurred. The 
‘time course of this effect at two different concen- 
trations of thrombin is shown in fig.2. At 
2.0 U/ml, thrombin reduced [32P]G-protein by 
73% within 10 s, thereafter it slowly increased to 
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Fig. 1. (A) Two-dimensional gel electrophoresis of 
membranes from unstimulated platelets showing 
position of [32P]ADP-ribosylated 40-41 kDa protein 
(pertussis toxin substrate). Inset shows SDS-gel of 
45 kDa and 40-41 kDa proteins ADP ribosylated by 
cholera toxin (CT) and pertussis toxin (PT), respectively 
(molecular mass scale is not same as on 2D gel). (B) 
Two-dimensional gel electrophoresis of [32P]phosphate 
loaded platelets treated with 100 ng/ml PMA for 5 min, 
showing a 40-41 kDa (P41) phosphoprotein at same 
position as the ADP-ribosylated protein. P47 is a major 
substrate for PMA-stimulated protein kinase C. 
within 80% of the prestimulus level after 5 min. At 
0.5 U/ml thrombin [32P]G-protein decreased by 
65%, but more slowly, reaching its lowest level 
after about 1 min. Interestingly, the subsequent in- 
crease of [32P]G-protein was also much slower, ris- 
ing to only 45% of the control level in 5 min, sug- 
gesting that the rate of reassociation of G-protein 
subunits @fly) was also influenced by the intensity 
of the stimulus. 
Hirudin, which strips thrombin from its recep- 
tors [28], rapidly reversed the fall of [“*PIG- 
protein when added 10 s after thrombin. [‘*PIG- 
protein returned to control levels in less than 60 s, 
and in fact rebounded to a level significantly above 
the prestimulus value by 5 min (fig.2). We con- 
clude that: (a) thrombin decreased ADP- 
ribosylatable G-protein, probably by causing 
dissociation of oligomer subunits; (b) despite con- 
tinuous occupancy of thrombin receptors the level 
of G-protein progressively returned toward normal 
at a rate that may be governed by some receptor- 
initiated reaction; (c) removal of thrombin from its 
receptors terminated the dissociating stimulus and 
allowed the restorative process to progress 
unimpeded at a much higher rate. 
Phosphoinositide hydrolysis and Ca*+ mobiliza- 
tion caused by thrombin are inhibited by tumor- 
promoting phorbol diesters and conditions that in- 
crease cyclic AMP [l&29-32]. Therefore, we 
studied the effects of PMA and PGDz on 
thrombin-induced issociation of G-protein. PMA 
(100 ng/ml) by itself increased ADP-ribosylatable 
G-protein by 51-68% within 5 min (table 2), an ef- 
fect similar to that seen previously in rabbit 
neutrophil membranes [33]; this increase of ADP- 
ribosylated protein above control levels (and in 
thrombin-stimulated cells after addition of 
hirudin) indicates that about 30% of the total G- 
protein may be present as free a-subunits in 
equilibrium with G-protein oligomers, as previous- 
ly shown in membrane fractions [34]. This 
Table 1 
Effect of stimulation of platelets with thrombin on basal 
and pertus& toxin induced [32P]ADP ribosylation of the 
40-41 kDa G-protein in membranes isolated from the 
intact platelets, as described in section 2 
Treatment Amount of “*P-labelled , 
40-41 kDa protein, 
each value relative to its 
own control (unstimulated)* 
Basal + pertussis toxin 
Unstimulated platelets 0 
:i; 
+ 0.5 U/ml thrombin 0 0.43 f 0.08 
(4) 
+ 1.0 U/ml thrombin 0 0.38 
(1) 
+ 2.0 U/ml thrombin 0 0.38 f 0.06 
(5) 
* Results expressed as means f SE, number of 
experiments in parentheses 
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MINUTES 
Fig.2. Effect of thrombin on ADP-ribosylatable 
40-41 kDa protein of platelet membranes. Platelets (5 x 
109/ml) were incubated with thrombin at 37’C for times 
indicated, and ADP ribosylation measured in isolated 
membrane fraction as described in section 2. 
equilibrium appears to be shifted towards dissocia- 
tion or reassociation by thrombin and protein 
kinase C, respectively. Protein kinase C [35] can 
phosphorylate free cu-subunits, and suppress their 
ability to inhibit adenylate cyclase [34]. In PMA- 
treated platelets we observed the phosphorylation 
of a 40-41 kDa polypeptide that migrated iden- 
tically to the [‘*P]ADP-ribosylated polypeptide on 
SDS-PAGE and after isoelectric focusing (fig. 1B). 
The concordance of G-protein phosphorylation 
with increased ADP-ribosylatable protein suggests 
that phosphorylation of a-subunits may promote 
their reassociation with other subunits @3~) to form 
oligomers of G-protein. Pretreatment with PMA 
did not prevent a fall of ADP-ribosylatable G- 
protein caused by thrombin (table 2). However, 
because the G-protein was initially elevated 
50-60% by PMA, thrombin reduced it only back 
to the normal prestimulus range. Thus, PMA did 
not prevent receptor-G-protein interactions but in 
effect somewhat attenuated the maximal extent of 
the dissociation of G-protein oligomers normally 
caused by thrombin. This accords with our 
previous findings that PMA could only partially 
inhibit hydrolysis of PIP?, and indicates that the 
much stronger inhibition of Ca’+ mobilization is 
caused by some additional action of PMA distal to 
phospholipase C [29], possibly by activating an IP3 
phosphatase (i.e. P47 protein) [36]. PGD2, which 
is a more effective inhibitor of PIP2 hydrolysis 
1321, acted quite differently from PMA; in 
unstimulated platelets G-protein was unaffected, 
but the fall caused by thrombin was virtually 
abolished (table 2). This suggests anew mechanism 
of action for cyclic AMP in platelets, namely to 
uncouple transduction of the stimulus from the 
thrombin receptor to G-protein. 
Thrombin receptors are involved in the inhibi- 
tion of adenylate cyclase and the activation of 
phospholipase C, but no link has been established 
between Gi, which is coupled to adenylate cyclase, 
and polyphosphoinositide metabolism. For exam- 
ple, cuz-adrenoreceptors which mediate the inhibi- 
tion of adenylate cyclase through Gi, do not ap- 
pear to stimulate phospholipase C. Furthermore, 
PAF-acether and U44069 stimulate a GTPase ac- 
tivity in platelet membranes that was relative resis- 
tant to pertussis toxin [37]. On the other hand, per- 
Table 2 
Effect of phorbol myristate acetate (PMA) and PGDz 
(+ theophylline) on 13’P]ADP ribosylation of 
40-41 kDa protein in unstimulated and thrombin- 
stimulated platelets 
Amount of 32P- 
labelled, 40-41 kDa 
protein (each value 
relative to its own 
control - 
unstimulated) 
Basal + pertussis 
toxin 
Untreated platelets 0 1.00 
+ PMA (100 ng/ml, 5 min) 0 1.54 
+ PMA 0 1.51 
+ PMA, then thrombin 
(2.0 U/ml, 30 s) 0 1.16 
+ PMA 0 1.68 
+ PMA, then thrombin 0 1.05 
Untreated platelets 0 1.00 
+ Thrombin (2.0 U/ml, 30 s) 0 0.24 
PGDz/theophylline (2 min), 
then thrombin (30 s) 0 1.14” 
+ Thrombin 0 0.37 
PGDz/theophylline, then thrombin 0 0.88 
a PGD2 + theophylline by themselves had no effect on 
ADP ribosylation 
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tussis toxin suppressed Ca” mobilization by 
thrombin in saponin-permeabilized platelets [38]. 
The pertussis toxin substrate in platelets is present 
in great excess over Gs [39], and thrombin recep- 
tors [41] greatly exceed crz-adrenoceptors 1401 
linked to Gi. In neutrophils only 10% of pertussis 
toxin substrate is detectable by Ga-antiserum, and 
90% is immunologically distinct from Ge or G& 
[42]. These facts suggest hat the pertussis toxin 
substrate in platelets may also be heterogeneous. 
Further work is necessary to characterize the ADP- 
ribosylated polypeptides in platelets, and to deter- 
mine if the effects of thrombin, PMA and PGDz 
on G-protein(s) are relevant to their regulation of 
phospholip~e C activity. 
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